Clinical and Academic Research Organizations

nView solutions have been used by researchers for over 25 years to increase accuracy of patient identification and decrease time needed for patient recruitment, ultimately helping organizations get their products to market faster and more safely.

Benefit from Proven Experience

nView screeners and assessment solutions have been used by large clinical trial organizations and pharmaceutical drug manufacturers to efficiently complete drug trials in more than 100 countries.

Ensure Validity of Study Results

nView’s M.I.N.I. solution has been cited in more than 17,000 regulatory and clinical studies, including those cited by the the FDA, National Institutes of Health (NIH), National Institutes of Mental Health (NIMH), World Health Organization (WHO), European Pharmaceutical Associations, Federation of Asian Pharmaceutical Associations, and many college/universities and medical schools.

Enable Global Reach

nView screening and assessment solutions have been translated to more than 70 different languages and used in studies across 100 countries, so your study can have virtually unlimited reach.

Increase Pool of Available Subjects

Utilize nView solutions can be utilized by the investigator with patients and by potential study volunteers directly.

nView’s Global Reach and Experience


Improve Accuracy of Patient Identification

Ensuring that all candidates have been properly screened for conditions that may impact study results, nView’s comprehensive solution ensures you are aware of underlying conditions, including suicidality and homicidally, that materially impact time and risk.

Decrease Time and Effort During Patient Recruitment Phase

The nView screeners take less than 3 minutes to complete and self-administered interviews take 20 minutes on average, reducing the time and effort required by your team to recruit quality candidates.

Want to learn how nView solutions benefit your research organization?